Quick Dispatch:
Your glp-1 and ampk GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1 and ampk GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways ships.
Need Help?
Questions about glp-1 and ampk GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 and ampk GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways in your area.
Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice
27.50
AMPK: Metabolism & Insulin + Ways to Activate
26.30
Exendin-4 exhibits cardioprotective effects against high glucose-induced mitochondrial abnormalities: Potential role of GLP-1 receptor and mTOR signaling
21.12
Frontiers
29.65
GLP-1 Agonists: Dual Benefits for Diabetes and Cancer
26.04
Glucagon-Like Peptide-1 and Its Implications in Obesity
27.18
Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases
25.52
